Neurelis
Neurelis is a pharmaceutical company founded in 2007, focused on developing and commercializing therapies for central nervous system disorders.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Neurelis was founded in 2007 with a vow to provide progressive solutions in therapeutic care to address unmet needs. The company was formed in San Diego to address unmet needs for central nervous system disorders. It licenses, develops, and commercializes product candidates for the broader central nervous system (CNS), including epilepsy and psychiatry. Neurelis has developed technologies such as Intravail® and ProTek® to enhance drug delivery and stability.
History
Neurelis was founded in 2007 with a vow to provide progressive solutions in therapeutic care to address unmet needs. It was formed in San Diego to address unmet needs for central nervous system disorders. The company licensed Intravail® absorption enhancement technology from Aegis Therapeutics, LLC. Over time, it explored various formulations, initiated clinical trials, received orphan drug designation and fast track designation from the FDA, filed a New Drug Application, and acquired Aegis Therapeutics, LLC.
Recent events
Reported
Neurelis partners with Rick Harrison on epilepsy education[6]
Neurelis announced a partnership with epilepsy education advocate Rick Harrison to raise awareness of epilepsy and the need for more education regarding seizure emergencies. The initiatives include Harrison meeting with physicians and community members and filming informational videos for distribution via social media in 2022.
Reported
Neurelis completes term loan facility from OrbiMed[7]
Neurelis announced that it completed a senior term loan facility of up to $150 million from OrbiMed to support commercialization of VALTOCO, pipeline development and potential strategic opportunities.
Sources7 sources
- 1Neurelis® Science & Technologies: Innovation Through Technologyneurelis.com
- 2About Neurelis®: Learn About Our Normal in Therapeuticsneurelis.com
- 3Neurelis, Inc.: Leadership in Pharmaceuticalsneurelis.com
- 4Neurelis Board of Directors: Driven to Achieve Progress in Biotechneurelis.com
- 5Neurelis (United States)wikidata.org
- 6Neurelis与Rick Harrison合作开展癫痫教育prnewswire.com
- 7Neurelis完成OrbiMed定期贷款融资prnewswire.com
Cite this profile: Cite the canonical profile. /brand-wiki/neurelis · Editorial policy · How profiles are compiled